Neurosense Therapeutics Ltd
NRSNW
Detailliertes Diagramm anzeigen
0.440USD
+0.090+25.61%
Handelsschluss 09/19, 16:00（ET）Kurse um 15 Minuten verzögert
0.00Marktkapitalisierung
--KGV TTM
Intraday
1m
30m
1h
D
W
M
D
Heute
+25.61%
5 Tage
+4.19%
1 Monat
-36.23%
6 Monate
+112.56%
Seit Jahresbeginn
0.00%
1 Jahr
+158.98%
Detailliertes Diagramm anzeigen
TradingKey Aktien-Score
Keine Bewertungsdaten
Nachrichten
Bald gibt es mehr Neuigkeiten, bleiben Sie dran...
Finanzindikatoren
EPS
Keine Daten
Gesamteinnahmen
Keine Daten
Unternehmen
NeuroSense Therapeutics Ltd is an Israel-based clinical-stage pharmaceutical company. The Company is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The Company's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease
BörsenkürzelNRSNW
UnternehmenNeurosense Therapeutics Ltd
CEOMr. Alon Ben-Noon
Websitehttps://www.neurosense-tx.com/
Verwandte Finanzinstrumente
+0.68%
+1.38%
-2.48%
-1.57%
-0.75%
-0.09%
+1.34%
-1.77%
-0.67%
-3.03%
-0.85%
-0.87%
-0.50%
+0.44%
-0.19%
-1.18%
-2.84%
0.00%
+0.30%
-3.72%
